Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Plasminogen-Aktivator-Inhibitor 1

Das SERPINE1-Gen kodiert den Plasminogen-Aktivator-Inhibitor 1 einem Regulator der Blutgerinnung. Mutationen führen zu einer autosomal dominanten oder rezessiven Blutungsneigung. Hohe Konzentrationen diese Proteins führen zur Thrombophilie.

Gentests:

Klinisch Untersuchungsmethoden Familienuntersuchung
Bearbeitungszeit 5 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Hochdurchsatz-Sequenzierung
Bearbeitungszeit 25 Tage
Probentyp genomische DNS
Forschung Untersuchungsmethoden Direkte Sequenzierung der proteinkodierenden Bereiche eines Gens
Bearbeitungszeit 25 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Direkte Sequenzierung ausgewählter Gen-Abschnitte
Bearbeitungszeit 5 Tage
Probentyp genomische DNS

Verknüpfte Erkrankungen:

Plasminogen-Aktivator-Inhibitor-Mangel
SERPINE1
PAI-Transkriptionsmodulator
SERPINE1

Referenzen:

1.

Yamada N et al. (2000) The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia.

external link
2.

Carmeliet P et al. (1997) Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice.

external link
3.

Margaglione M et al. (1998) The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease.

external link
4.

Pastinen T et al. (1998) Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population.

external link
5.

Hermans PW et al. (1999) 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group.

external link
6.

Westendorp RG et al. (1999) Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock.

external link
7.

Yoon S et al. (1999) Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms.

external link
8.

Halleux CM et al. (1999) Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines.

external link
9.

Rossaak JI et al. (2000) Association of the 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor-1 with abdominal aortic aneurysms.

external link
10.

Boccaccio C et al. (2005) The MET oncogene drives a genetic programme linking cancer to haemostasis.

external link
11.

Kohler HP et al. (2000) Plasminogen-activator inhibitor type 1 and coronary artery disease.

external link
12.

Crandall DL et al. (2000) Autocrine regulation of human preadipocyte migration by plasminogen activator inhibitor-1.

external link
13.

Maemura K et al. (2000) CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression.

external link
14.

Fujita T et al. (2001) Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis.

external link
15.

Yamamoto K et al. (2002) Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals.

external link
16.

Yamada Y et al. (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes.

external link
17.

Patel N et al. (2011) Involvement of miR-30c and miR-301a in immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cells.

external link
18.

Glueck CJ et al. (1993) Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis?

external link
19.

Sawathiparnich P et al. (2003) Effect of combined AT1 receptor and aldosterone receptor antagonism on plasminogen activator inhibitor-1.

external link
20.

Fay WP et al. (1992) Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation.

external link
21.

Fay WP et al. (1997) Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene.

external link
22.

Zhang ZY et al. (2005) A case of deficiency of plasma plasminogen activator inhibitor-1 related to Ala15Thr mutation in its signal peptide.

external link
23.

Mehta R et al. (2008) Plasminogen activator inhibitor type 1 deficiency.

external link
24.

Erickson LA et al. (1990) Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene.

external link
25.

Pannekoek H et al. (1986) Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family.

external link
26.

Engesser L et al. (1989) Elevated plasminogen activator inhibitor (PAI), a cause of thrombophilia? A study in 203 patients with familial or sporadic venous thrombophilia.

external link
27.

Loskutoff DJ et al. (1987) Structure of the human plasminogen activator inhibitor 1 gene: nonrandom distribution of introns.

external link
28.

van Zonneveld AJ et al. (1988) Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter.

external link
29.

Klinger KW et al. (1987) Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis.

external link
30.

Ny T et al. (1986) Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.

external link
31.

Ginsburg D et al. (1986) cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.

external link
32.

Nilsson IM et al. (1985) Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.

external link
33.

Eriksson P et al. (1995) Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.

external link
34.

Dawson SJ et al. (1993) The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells.

external link
35.

OMIM.ORG article

Omim 173360 external link
36.

NCBI article

NCBI 5054 external link
37.

Orphanet article

Orphanet ID 118613 external link
38.

Wikipedia Artikel

Wikipedia DE (Plasminogen-Aktivator-Inhibitor) external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz